vs
Side-by-side financial comparison of NewGenIvf Group Ltd (NIVF) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
NewGenIvf Group Ltd is a specialized assisted reproductive technology (ART) service provider. It offers a full range of fertility solutions including in vitro fertilization, preimplantation genetic testing and fertility preservation, primarily serving clients across Greater China and Southeast Asia, including both local and cross-border patients seeking reproductive care.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $76.2M | ||
| Q3 25 | — | $71.9M | ||
| Q2 25 | — | $63.1M | ||
| Q1 25 | — | $59.1M | ||
| Q4 24 | — | $60.7M | ||
| Q3 24 | — | $58.0M | ||
| Q2 24 | — | $55.0M | ||
| Q1 24 | — | $50.6M |
| Q4 25 | — | $5.6M | ||
| Q3 25 | — | $3.5M | ||
| Q2 25 | — | $3.2M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | — | 11.0% | ||
| Q3 25 | — | 7.8% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 4.4% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | 5.0% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | $0.14 | ||
| Q3 25 | — | $0.09 | ||
| Q2 25 | — | $0.08 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.04 | ||
| Q1 24 | — | $0.04 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
